The reach of the Taubman Institute extends beyond our scholars’ laboratories; we’re also funding the Consortium for Stem Cell Therapies, where stem cell lines are developed and distributed. The Consortium already has become a recognized leader, developing one of the nation’s first embryonic stem cell lines.
And in the spirit of sharing and collaboration, we’re facilitating the exchange of ideas among scientific colleagues from across campus and across the ocean by sponsoring opportunities for visionary scientists to share ideas and knowledge.
Current programs include our monthly Taubman Talks and the new Visiting Professor lecture series, which invites scientists nominated by Taubman Scholars to speak at public lectures on the Medical School campus.
Our Israel Initiative has brought eminent scientists from Israel to Ann Arbor for meetings with local researchers.
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
Is there a link between tonsils and psoriasis?
Trial tested the effect of tonsillectomy on the skin disease
Taubman Emerging Scholar Dr. Johann Gudjonsson and colleagues found that people who had their tonsils removed showed improvment.
Click here to read the entire story
Fall Visiting Professor Lectures schedule
Distinguished guest speakers include experts in lung, muscle and nerve diseases
Click here for the lineup
Breast cancer clinical trial enrolling patients
Research by Taubman Scholar Dr. Max Wicha into breast cancer stem cells is the basis for a new human clinical trial of the drug Reparixin, which scientists hope will curb the growth of the tumor-fueling cells.